 | • レポートコード：MRC2102QY9085 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の片頭痛治療薬市場について種類別（スマトリプタン、ゾルミトリプタン、リザトリプタン、その他薬剤）、用途別（病院、クリニック、家庭、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・片頭痛治療薬市場の概要 ・世界の主要地域別片頭痛治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の片頭痛治療薬市場規模2015-2026：種類別（スマトリプタン、ゾルミトリプタン、リザトリプタン、その他薬剤） ・世界の片頭痛治療薬市場規模2015-2026：用途別（病院、クリニック、家庭、その他） ・片頭痛治療薬の米国市場規模2015-2020 ・片頭痛治療薬のヨーロッパ市場規模2015-2020 ・片頭痛治療薬の中国市場規模2015-2020 ・片頭痛治療薬の日本市場規模2015-2020 ・片頭痛治療薬の東南アジア市場規模2015-2020 ・片頭痛治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・片頭痛治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・片頭痛治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Migraine Drugs Market
The global Migraine Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Migraine Drugs Scope and Market Size
The global Migraine Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Migraine Drugs market is segmented into
Sumatriptan
Zolmitriptan
Rizatriptan
Others Drug
Segment by Application, the Migraine Drugs market is segmented into
Hospitals
Clinics
Household Use
Others
The Migraine Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Migraine Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Migraine Drugs Market Share Analysis
Migraine Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Migraine Drugs business, the date to enter into the Migraine Drugs market, Migraine Drugs product introduction, recent developments, etc.
The major vendors covered:
Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
1 Migraine Drugs Market Overview
1.1 Migraine Drugs Product Scope
1.2 Migraine Drugs Segment by Type
1.2.1 Global Migraine Drugs Sales by Type (2020-2026)
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Migraine Drugs Segment by Application
1.3.1 Global Migraine Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Migraine Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Migraine Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Migraine Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Migraine Drugs Price Trends (2015-2026)
2 Migraine Drugs Estimate and Forecast by Region
2.1 Global Migraine Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Migraine Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Migraine Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Migraine Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Migraine Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Migraine Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Migraine Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Migraine Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Migraine Drugs Estimates and Projections (2015-2026)
2.4.3 China Migraine Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Migraine Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Migraine Drugs Estimates and Projections (2015-2026)
2.4.6 India Migraine Drugs Estimates and Projections (2015-2026)
3 Global Migraine Drugs Competition Landscape by Players
3.1 Global Top Migraine Drugs Players by Sales (2015-2020)
3.2 Global Top Migraine Drugs Players by Revenue (2015-2020)
3.3 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Drugs as of 2019)
3.4 Global Migraine Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Migraine Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Migraine Drugs Players (Opinion Leaders)
4 Global Migraine Drugs Market Size by Type
4.1 Global Migraine Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Migraine Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Migraine Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Migraine Drugs Price by Type (2015-2020)
4.2 Global Migraine Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Migraine Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Migraine Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Migraine Drugs Price Forecast by Type (2021-2026)
5 Global Migraine Drugs Market Size by Application
5.1 Global Migraine Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Migraine Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Migraine Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Migraine Drugs Price by Application (2015-2020)
5.2 Global Migraine Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Migraine Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Migraine Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Migraine Drugs Price Forecast by Application (2021-2026)
6 United States Migraine Drugs Market Facts & Figures
6.1 United States Migraine Drugs Sales Market Share by Company (2015-2020)
6.2 United States Migraine Drugs Sales Market Share by Type (2015-2020)
6.3 United States Migraine Drugs Sales Market Share by Application (2015-2020)
7 Europe Migraine Drugs Market Facts & Figures
7.1 Europe Migraine Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Migraine Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Migraine Drugs Sales Market Share by Application (2015-2020)
8 China Migraine Drugs Market Facts & Figures
8.1 China Migraine Drugs Sales Market Share by Company (2015-2020)
8.2 China Migraine Drugs Sales Market Share by Type (2015-2020)
8.3 China Migraine Drugs Sales Market Share by Application (2015-2020)
9 Japan Migraine Drugs Market Facts & Figures
9.1 Japan Migraine Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Migraine Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Migraine Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Migraine Drugs Market Facts & Figures
10.1 Southeast Asia Migraine Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Migraine Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Migraine Drugs Sales Market Share by Application (2015-2020)
11 India Migraine Drugs Market Facts & Figures
11.1 India Migraine Drugs Sales Market Share by Company (2015-2020)
11.2 India Migraine Drugs Sales Market Share by Type (2015-2020)
11.3 India Migraine Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Migraine Drugs Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Migraine Drugs Products Offered
12.1.5 Allergan Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Migraine Drugs Products Offered
12.2.5 Merck Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Migraine Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Business Overview
12.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teva Migraine Drugs Products Offered
12.4.5 Teva Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Migraine Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Migraine Drugs Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Endo International
12.7.1 Endo International Corporation Information
12.7.2 Endo International Business Overview
12.7.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Endo International Migraine Drugs Products Offered
12.7.5 Endo International Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Business Overview
12.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline Migraine Drugs Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 Impax
12.9.1 Impax Corporation Information
12.9.2 Impax Business Overview
12.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Impax Migraine Drugs Products Offered
12.9.5 Impax Recent Development
12.10 Abbott
12.10.1 Abbott Corporation Information
12.10.2 Abbott Business Overview
12.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Abbott Migraine Drugs Products Offered
12.10.5 Abbott Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Business Overview
12.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer Migraine Drugs Products Offered
12.11.5 Bayer Recent Development
12.12 Eli Lilly
12.12.1 Eli Lilly Corporation Information
12.12.2 Eli Lilly Business Overview
12.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Eli Lilly Migraine Drugs Products Offered
12.12.5 Eli Lilly Recent Development
12.13 Ethypharm
12.13.1 Ethypharm Corporation Information
12.13.2 Ethypharm Business Overview
12.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Ethypharm Migraine Drugs Products Offered
12.13.5 Ethypharm Recent Development
12.14 Kowa Pharmaceuticals America
12.14.1 Kowa Pharmaceuticals America Corporation Information
12.14.2 Kowa Pharmaceuticals America Business Overview
12.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Kowa Pharmaceuticals America Migraine Drugs Products Offered
12.14.5 Kowa Pharmaceuticals America Recent Development
12.15 Winston Pharmaceuticals
12.15.1 Winston Pharmaceuticals Corporation Information
12.15.2 Winston Pharmaceuticals Business Overview
12.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Winston Pharmaceuticals Migraine Drugs Products Offered
12.15.5 Winston Pharmaceuticals Recent Development
12.16 AstraZeneca
12.16.1 AstraZeneca Corporation Information
12.16.2 AstraZeneca Business Overview
12.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 AstraZeneca Migraine Drugs Products Offered
12.16.5 AstraZeneca Recent Development
13 Migraine Drugs Manufacturing Cost Analysis
13.1 Migraine Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Migraine Drugs
13.4 Migraine Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Migraine Drugs Distributors List
14.3 Migraine Drugs Customers
15 Market Dynamics
15.1 Migraine Drugs Market Trends
15.2 Migraine Drugs Opportunities and Drivers
15.3 Migraine Drugs Market Challenges
15.4 Migraine Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Migraine Drugs Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Migraine Drugs Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Migraine Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Migraine Drugs Sales (MT) by Region (2015-2020)
Table 5. Global Migraine Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Migraine Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Migraine Drugs Revenue Share by Region (2015-2020)
Table 8. Global Migraine Drugs Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Migraine Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Migraine Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Migraine Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Migraine Drugs (MT) of Key Companies (2015-2020)
Table 13. Global Migraine Drugs Sales Share by Company (2015-2020)
Table 14. Global Migraine Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Migraine Drugs Revenue Share by Company (2015-2020)
Table 16. Global Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Drugs as of 2019)
Table 17. Global Migraine Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Migraine Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Migraine Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Migraine Drugs Players
Table 22. Global Migraine Drugs Sales (MT) by Type (2015-2020)
Table 23. Global Migraine Drugs Sales Share by Type (2015-2020)
Table 24. Global Migraine Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Migraine Drugs Price (MT) by Type (2015-2020)
Table 26. Global Migraine Drugs Sales Share by Type (2021-2026)
Table 27. Global Migraine Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Migraine Drugs Revenue Share by Type (2021-2026)
Table 29. Global Migraine Drugs Price (MT) by Type (2021-2026)
Table 30. Global Migraine Drugs Sales (MT) by Application (2015-2020)
Table 31. Global Migraine Drugs Sales Share by Application (2015-2020)
Table 32. Global Migraine Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Migraine Drugs Price (MT) by Application (2015-2020)
Table 34. Global Migraine Drugs Sales (MT) by Application (2021-2026)
Table 35. Global Migraine Drugs Sales Share by Application (2021-2026)
Table 36. Global Migraine Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Migraine Drugs Revenue Share by Application (2021-2026)
Table 38. Global Migraine Drugs Price (MT) by Application (2021-2026)
Table 39. United States Migraine Drugs Sales (MT) by Company (2015-2020)
Table 40. United States Migraine Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Migraine Drugs Sales (MT) by Type (2015-2020)
Table 42. United States Migraine Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Migraine Drugs Sales (MT) by Application (2015-2020)
Table 44. United States Migraine Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Migraine Drugs Sales (MT) by Company (2015-2020)
Table 46. Europe Migraine Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Migraine Drugs Sales (MT) by Type (2015-2020)
Table 48. Europe Migraine Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Migraine Drugs Sales (MT) by Application (2015-2020)
Table 50. Europe Migraine Drugs Sales Market Share by Type (2015-2020)
Table 51. China Migraine Drugs Sales (MT) by Company (2015-2020)
Table 52. China Migraine Drugs Sales Market Share by Company (2015-2020)
Table 53. China Migraine Drugs Sales (MT) by Type (2015-2020)
Table 54. China Migraine Drugs Sales Market Share by Type (2015-2020)
Table 55. China Migraine Drugs Sales (MT) by Application (2015-2020)
Table 56. China Migraine Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Migraine Drugs Sales (MT) by Company (2015-2020)
Table 58. Japan Migraine Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Migraine Drugs Sales (MT) by Type (2015-2020)
Table 60. Japan Migraine Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Migraine Drugs Sales (MT) by Application (2015-2020)
Table 62. Japan Migraine Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Migraine Drugs Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Migraine Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Migraine Drugs Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Migraine Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Migraine Drugs Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Migraine Drugs Sales Market Share by Application (2015-2020)
Table 69. India Migraine Drugs Sales (MT) by Company (2015-2020)
Table 70. India Migraine Drugs Sales Market Share by Company (2015-2020)
Table 71. India Migraine Drugs Sales (MT) by Type (2015-2020)
Table 72. India Migraine Drugs Sales Market Share by Type (2015-2020)
Table 73. India Migraine Drugs Sales (MT) by Application (2015-2020)
Table 74. India Migraine Drugs Sales Market Share by Application (2015-2020)
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Allergan Migraine Drugs Product
Table 79. Allergan Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Migraine Drugs Product
Table 84. Merck Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Migraine Drugs Product
Table 89. Pfizer Recent Development
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Teva Migraine Drugs Product
Table 94. Teva Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pfizer Migraine Drugs Product
Table 99. Pfizer Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Migraine Drugs Product
Table 104. Johnson & Johnson Recent Development
Table 105. Endo International Corporation Information
Table 106. Endo International Description and Business Overview
Table 107. Endo International Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Endo International Migraine Drugs Product
Table 109. Endo International Recent Development
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Description and Business Overview
Table 113. GlaxoSmithKline Migraine Drugs Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Impax Corporation Information
Table 116. Impax Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Impax Description and Business Overview
Table 118. Impax Migraine Drugs Product
Table 119. Impax Recent Development
Table 120. Abbott Corporation Information
Table 121. Abbott Description and Business Overview
Table 122. Abbott Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Abbott Migraine Drugs Product
Table 124. Abbott Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Bayer Migraine Drugs Product
Table 129. Bayer Recent Development
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Business Overview
Table 132. Eli Lilly Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Eli Lilly Migraine Drugs Product
Table 134. Eli Lilly Recent Development
Table 135. Ethypharm Corporation Information
Table 136. Ethypharm Description and Business Overview
Table 137. Ethypharm Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Ethypharm Migraine Drugs Product
Table 139. Ethypharm Recent Development
Table 140. Kowa Pharmaceuticals America Corporation Information
Table 141. Kowa Pharmaceuticals America Description and Business Overview
Table 142. Kowa Pharmaceuticals America Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Kowa Pharmaceuticals America Migraine Drugs Product
Table 144. Kowa Pharmaceuticals America Recent Development
Table 145. Winston Pharmaceuticals Corporation Information
Table 146. Winston Pharmaceuticals Description and Business Overview
Table 147. Winston Pharmaceuticals Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Winston Pharmaceuticals Migraine Drugs Product
Table 149. Winston Pharmaceuticals Recent Development
Table 150. AstraZeneca Corporation Information
Table 151. AstraZeneca Description and Business Overview
Table 152. AstraZeneca Migraine Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. AstraZeneca Migraine Drugs Product
Table 154. AstraZeneca Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Migraine Drugs Distributors List
Table 158. Migraine Drugs Customers List
Table 159. Migraine Drugs Market Key Trends
Table 160. Migraine Drugs Key Opportunities and Drivers
Table 161. Migraine Drugs Market Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Migraine Drugs Product Picture
Figure 2. Global Migraine Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Migraine Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Household Use Examples
Figure 9. Others Examples
Figure 10. Global Migraine Drugs Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Migraine Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Migraine Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Migraine Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Migraine Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Migraine Drugs Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Migraine Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Migraine Drugs Players Market Share by Revenue in Migraine Drugs 2015 & 2019
Figure 28. Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Migraine Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Migraine Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Migraine Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Migraine Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Migraine Drugs Sales Market Share by Type in 2019
Figure 34. United States Migraine Drugs Sales Market Share by Type in 2019
Figure 35. Europe Migraine Drugs Sales Market Share by Company in 2019
Figure 36. Europe Migraine Drugs Sales Market Share by Type in 2019
Figure 37. Europe Migraine Drugs Sales Market Share by Application in 2019
Figure 38. China Migraine Drugs Sales Market Share by Company in 2019
Figure 39. China Migraine Drugs Sales Market Share by Type in 2019
Figure 40. China Migraine Drugs Sales Market Share by Application in 2019
Figure 41. Japan Migraine Drugs Sales Market Share by Company in 2019
Figure 42. Japan Migraine Drugs Sales Market Share by Type in 2019
Figure 43. Japan Migraine Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Migraine Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Migraine Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Migraine Drugs Sales Market Share by Application in 2019
Figure 47. India Migraine Drugs Sales Market Share by Company in 2019
Figure 48. India Migraine Drugs Sales Market Share by Type in 2019
Figure 49. India Migraine Drugs Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Migraine Drugs
Figure 52. Manufacturing Process Analysis of Migraine Drugs
Figure 53. Migraine Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
疼痛管理薬・デバイスの世界市場レポート2020 Market Analysis and Insights: Global Pain Management Drugs & Devices Market The global Pain Management Drugs & Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pain Management Drugs & Devices Scope and Market Siz…- 麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …
- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…
- 副腎白質ジストロフィー治療薬の世界市場レポート2020 Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP). Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatt…
- 非ステロイド性抗炎症薬の世界市場レポート2020 Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune dis…